Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasuda, S.
Right arrow Articles by Horiuchi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuda, S.
Right arrow Articles by Horiuchi, M.

Radiology, Vol 207, 775-778, Copyright © 1998 by Radiological Society of North America


ARTICLES

Chronic thyroiditis: diffuse uptake of FDG at PET

S Yasuda, A Shohtsu, M Ide, S Takagi, W Takahashi, Y Suzuki and M Horiuchi
HIMEDIC Imaging Center at Lake Yamanaka, Yamanashi, Japan.

PURPOSE: To determine the frequency and clinical importance of diffuse 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland. MATERIALS AND METHODS: A total of 1,102 healthy subjects underwent whole-body positron emission tomography (PET). PET images were evaluated for increased diffuse FDG uptake in the thyroid gland. Serum free thyroxine and thyrotropin levels were measured in 36 subjects with increased uptake and in 36 matched control subjects without uptake. Antithyroid antibodies were also measured. Morphologic abnormalities were examined by using ultrasonography (US). RESULTS: Diffuse FDG uptake was found in three men and 33 women; the prevalence was significantly higher in women (P < .01). Thirty-five subjects were euthyroid; one had hypothyroidism. Antithyroid antibodies were positive in 27 subjects. In most subjects, US findings facilitated the diagnosis of chronic thyroiditis. In control subjects, the positive rates for antithyroid antibodies and US abnormalities were significantly lower than those of the study group (P < .01). CONCLUSION: Diffuse thyroidal FDG uptake may be an indicator of chronic thyroiditis. The actual prevalence of the disorder was not low in this series, and such lesions may be found incidentally at FDG PET.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
F. M. Sebastianes, J. J. Cerci, P. H. Zanoni, J. Soares Jr., L. K. Chibana, E. K. Tomimori, R. Y. A. de Camargo, M. Izaki, M. C. P. Giorgi, J. Eluf-Neto, et al.
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Preoperative Assessment of Cytologically Indeterminate Thyroid Nodules
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4485 - 4488.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. Karantanis, T. V. Bogsrud, G. A. Wiseman, B. P. Mullan, R. M. Subramaniam, M. A. Nathan, P. J. Peller, R. S. Bahn, and V. J. Lowe
Clinical Significance of Diffusely Increased 18F-FDG Uptake in the Thyroid Gland
J. Nucl. Med., June 1, 2007; 48(6): 896 - 901.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. M. Kim, J.-S. Ryu, T. Y. Kim, W. B. Kim, G. Y. Kwon, G. Gong, D. H. Moon, S. C. Kim, S. J. Hong, and Y. K. Shong
18F-Fluorodeoxyglucose Positron Emission Tomography Does Not Predict Malignancy in Thyroid Nodules Cytologically Diagnosed as Follicular Neoplasm
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1630 - 1634.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
C. Are, J. F. Hsu, H. Schoder, J. P. Shah, S. M. Larson, and A. R. Shaha
FDG-PET Detected Thyroid Incidentalomas: Need for Further Investigation?
Ann. Surg. Oncol., January 1, 2007; 14(1): 239 - 247.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Quon, N. J. Fischbein, I. R. McDougall, Q.-T. Le, B. W. Loo Jr., H. Pinto, and M. J. Kaplan
Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma
J. Nucl. Med., January 1, 2007; 48(1_suppl): 58S - 67S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Y. Choi, K. S. Lee, H.-J. Kim, Y. M. Shim, O. J. Kwon, K. Park, C.-H. Baek, J. H. Chung, K.-H. Lee, and B.-T. Kim
Focal Thyroid Lesions Incidentally Identified by Integrated 18F-FDG PET/CT: Clinical Significance and Improved Characterization
J. Nucl. Med., April 1, 2006; 47(4): 609 - 615.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. G. Yi, E. M. Marom, R. F. Munden, M. T. Truong, H. A. Macapinlac, G. W. Gladish, B. S. Sabloff, and D. A. Podoloff
Focal Uptake of Fluorodeoxyglucose by the Thyroid in Patients Undergoing Initial Disease Staging with Combined PET/CT for Non-Small Cell Lung Cancer
Radiology, July 1, 2005; 236(1): 271 - 275.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. Nakamoto, M. Tatsumi, D. Hammoud, C. Cohade, M. M. Osman, and R. L. Wahl
Normal FDG Distribution Patterns in the Head and Neck: PET/CT Evaluation
Radiology, March 1, 2005; 234(3): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. W. Kang, S.-K. Kim, H.-S. Kang, E. S. Lee, J. S. Sim, I. G. Lee, S.-Y. Jeong, and S. W. Kim
Prevalence and Risk of Cancer of Focal Thyroid Incidentaloma Identified by 18F-Fluorodeoxyglucose Positron Emission Tomography for Metastasis Evaluation and Cancer Screening in Healthy Subjects
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4100 - 4104.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Van den Bruel, A. Maes, T. De Potter, L. Mortelmans, M. Drijkoningen, B. Van Damme, P. Delaere, and R. Bouillon
Clinical Relevance of Thyroid Fluorodeoxyglucose-Whole Body Positron Emission Tomography Incidentaloma
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1517 - 1520.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. Grunwald and H.-J. Biersack
FDG PET in Thyroid Cancer: Thyroxine or Not?
J. Nucl. Med., December 1, 2000; 41(12): 1996 - 1998.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1998 by the Radiological Society of North America.